Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB08834
http://purl.obolibrary.org/obo/dinto_DB08834
|
|---|---|
| Preferred Name | tauroursodeoxycholic acid |
| Synonyms |
2-{4-[(1S,2S,5R,7S,9S,10R,11S,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0?,?.0??,??]heptadecan-14-yl]pentanamido}ethane-1-sulfonic acid
C26H45NO6S
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | tauroursodeoxycholic acid
|
|---|---|
| label | tauroursodeoxycholic acid
|
| DBSynonym |
tauroursodeoxycholate
tudca
|
| Definition | Tauroursodeoxycholic acid is the more hydrophilic form of ursodeoxycholic acid, which is the more abundant naturally produced bile acid in humans. Tauroursodeoxycholic acid, on the other hand, is produced abundantly in bears and has been used for centuries as a natural remedy in some Asian countries. It is approved in Italy and Turkey for the treatment of cholesterol gallstones and is an investigational drug in China, Unites States, and Italy. Tauroursodeoxycholic acid is being investigated for use in several conditions such as Primary Biliary Cirrhosis (PBC), insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis. The only completed clinical trial thus far is a phase III clinical trial comparing tauroursodeoxycholic acid and ursofalk in PBC adult patients, but as of June 2013 no results of this trial have been published.
|
| induces |
See more
See less
|
| type | |
| InChIKey | InChIKey=BHTRKEVKTKCXOH-CNHNFURNNA-N
|
| Synonym | 2-{4-[(1S,2S,5R,7S,9S,10R,11S,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0?,?.0??,??]heptadecan-14-yl]pentanamido}ethane-1-sulfonic acid
C26H45NO6S
|
| xref |
Drugs.com:http://www.drugs.com/international/tauroursodeoxycholic-acid.html
Wikipedia:http://en.wikipedia.org/wiki/Tauroursodeoxycholic_acid
|
| CASRN | 14605-22-2
|
| prefixIRI | obo2:dinto_DB08834
|
| related with | |
| SMILES | [H][C@@]12CCC(C(C)CCC(=O)NCCS(O)(=O)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C[C@]2([H])C[C@H](O)CC[C@]12C
|
| InChI | InChI=1/C26H45NO6S/c1-16(4-7-23(30)27-12-13-34(31,32)33)19-5-6-20-24-21(9-11-26(19,20)3)25(2)10-8-18(28)14-17(25)15-22(24)29/h16-22,24,28-29H,4-15H2,1-3H3,(H,27,30)(H,31,32,33)/t16?,17-,18+,19?,20-,21-,22-,24-,25-,26+/s2
|
| DBBrand |
tauro
taurolite
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |